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Abstract
Rift Valley fever virus (Phlebovirus, Bunyaviridae) is an arbovirus causing intermittent epizootics and sporadic epidemics
primarily in East Africa. Infection causes severe and often fatal illness in young sheep, goats and cattle. Domestic
animals and humans can be contaminated by close contact with infectious tissues or through mosquito infectious
bites. Rift Valley fever virus was historically restricted to sub-Saharan countries. The probability of Rift Valley fever
emerging in virgin areas is likely to be increasing. Its geographical range has extended over the past years. As a recent
example, autochthonous cases of Rift Valley fever were recorded in 2007–2008 in Mayotte in the Indian Ocean. It has
been proposed that a single infected animal that enters a naive country is sufficient to initiate a major outbreak before
Rift Valley fever virus would ever be detected. Unless vaccines are available and widely used to limit its expansion, Rift
Valley fever will continue to be a critical issue for human and animal health in the region of the Indian Ocean.
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1. Disease and transmission
Rift Valley fever (RVF) is an emerging zoonotic vector-
borne disease representing a threat to animal and human
health, and livestock production. Abortions and high mor-
talities in newborns are observed in animals [1,2]. In
humans, symptoms vary from a flu-like syndrome to en-
cephalitic, ocular or hemorrhagic syndrome. The case fa-
tality rate of the latter form can be as high as 50% [3].
Since its first isolation in 1930 in Kenya [4], RVF out-
breaks have been reported in most sub-Saharan coun-
tries, especially the Rift Valley in Kenya and Tanzania [5]
(Figure 1). Subsequent outbreaks with human cases have
been reported in South Africa [6] and the Nile Valley
from Sudan to the Egyptian delta [7]. The disease spread
from continental Africa to Madagascar in 1991 [8-11] and
in the Arabian Peninsula in 2000 [12]. In Madagascar,
RVFV was isolated for the first time in 1979 from pools of
mosquitoes captured during the rainy season in the pri-
mary rain forest of Perinet, Moramanga district [13]. The
most recent RVF outbreaks were detected in Somalia
(2006–2007) [14], Kenya (2006–2007) [15], Tanzania
(2007) [14], Sudan (2007–2008) [16], Madagascar (2008–
2009) [17], South Africa (2008, 2009, and 2010) [18],
Mauritania (2010) [19], Botswana (2010) [20], and
Namibia (2010) [21]. In Mayotte, sporadic cases in live-
stock have been recorded since 2004 with human cases
detected in 2007–2008 and 2011. While RVF was originally
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Figure 1 Geographical distribution of Rift Valley fever. Rift valley fever is historically endemic to many countries of sub-Saharan Africa. It
spread from continental Africa to Madagascar in 1991 and in the Arabian Peninsula in 2000. In Mayotte in the Indian Ocean, RVF cases have been
reported since 2004.
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associated with livestock mortality, recent outbreaks have
resulted in increased fatality rates in humans [16].
Rift Valley fever virus (RVFV) is transmitted among
ruminants by mosquito bites mainly belonging to the
Aedes and Culex genera and by direct contact with body
fluids of viremic animals. Moreover, biological or mech-
anical transmission of RVFV was reproduced experimen-
tally with other hematophagous flies but field relevance
of these transmission routes are still unclear [22,23].
Humans are mainly infected by close contact with blood,
excreta of infected animals, consumption of raw milk
[24], and in some rare cases, through mosquito bites
[25] (Figure 2).
RVFV circulates between animals within an enzootic
cycle during most years, but may become epizootic dur-
ing wet years in regions such as East Africa. Virus is
maintained during dry seasons in desiccation-resistant
eggs of several Aedes species which have acquired the
virus by vertical transmission [26]. For example, in East
Africa, flooding of natural excavations lead to the hatch-
ing of large numbers of Aedes (Aedimorphus and
Neomelaniconion subgenera) eggs initiating viral circula-
tion. Movements of viremic animals along trade routes
have been suspected to be responsible for the virus
spreading [27]. Unless vaccines are used on a large scale
in Africa, RVF will continue to be a significant problem
with the fear of being introduced into western countries.
In the Indian Ocean, RVF was described in Madagascar,
Mayotte and other islands of Comoros. In Madagascar,
RVFV was first isolated in 1979 from mosquitoes [28].
The isolated viral strains were closely related to Egyptian
strains. Later, epizootics in 1990 involved viral strains gen-
etically close to strains from Zimbabwe [11,29]. The first
human cases were only reported during the 2008 out-
break; 417 cases were suspected with 59 laboratory con-
firmed, and 19 deaths [17]. The proximity with East Africa
may favor recurrent RVF introduction via livestock trade
[29]. A survey conducted in 2009 in cattle from a pilot
area in Madagascar highlands demonstrated a recurrent
circulation of RVFV [30]. In this temperate and mountain-
ous region, the climate is not favourable to RVFV vectors.
Therefore, the involvement of cattle in virus circulation
and persistence was suspected. In the same area, two dis-
tinct trading practices have been described [31]: usual
trade and a traditional barter practice named kapsile. To
conclude the barter, the applicant has to exhibit his cattle
allowing frequent contact between animals and people.
Social network analysis methods suggested that networks
could be formed by preferential attachment mechanisms,
due to a better reputation of some breeders or villages.
The results highlighted the need for a careful description
of exchange practices for the understanding of the RVFV
circulation mechanisms. Due to links with markets located
in RVFV-affected areas during the 2008–2009 outbreak,
the usual trade network could support virus introduction
from other parts of Madagascar. A protective effect of the
village distance to the nearest water point which suggested
a vector-borne transmission could partly support disease
transmission in the highlands area.
In Mayotte, a human case was reported in August
2007 suggesting an autochthonous circulation of RVF on
this island of the Comoros archipelago [32]. Amongst
the 488 sera sampled from ruminants, 32.8% were found
to be serologically positive during the 2009 dry season
[33]. Serological surveys of ruminants showed a RVF cir-
culation on Mayotte as early as 2004 without any human
or animal cases detected [34].
2. Mosquito vectors
Eighteen out of more than 65 mosquito species de-
scribed as potential vectors of RVFV worldwide, have
been found in Madagascar [28]. Aedes species of the
subgenus Neomelaniconion, incriminated in the vertical
transmission of RVFV in Kenya were also present on the
island [28]. Four periods can be defined in RVF history
in Madagascar:
(i) 1979 with the first detection of RVFV. The virus
was first isolated in 1979 from multispecific pools of
Anopheles (An. coustani, An. fuscicolor, An. pauliani,
An. squamosus), Culex (Culex simpsoni, Cx.
vansomereni, Cx. antennatus, Cx. quinquefasciatus,
Cx. annulioris, Cx. univittatus), Mansonia uniformis
and Coquillettidia grandidieri [35] during the rainy
season in the forest area of Périnet in the district of
Moramanga. However, this study was not able to
give the accurate implication of each species in the
RVF transmission or their role in the maintenance
of the virus during the inter-epizootic period.
(ii)1990–1991 with the first epizootics. During the first
epizootics of RVF in the Malagasy livestock described
in the east coast and the highlands, respectively, in
1990 and 1991, thousands of mosquitoes were
collected but no virus was isolated [8-11].
(iii)1993–2008 with RVFV detected in Malagasy cattle
during the inter-epizootic period. From 1993 to 2008,
the virus was not detected in more than 150 000
mosquitoes tested (Anopheles, Culex, Aedes,
Mansonia, Aedemomyia, Coquillettidia,
Eretmapodites, Mansonia, and Uranotaenia) despite
its circulation in livestock and its maintenance at a
low level [28,36,37].
(iv) 2008–2009 with the last epizootic. Recently, in
2008–2009, RVF was recorded in humans and cattle
in several districts of Madagascar [17] with a broad
distribution of the virus on the island [38]. These
re-emergences during two rainy seasons suggested
the role of mosquitoes in the transmission of RVF:
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Figure 2 Cycle of Rift Valley fever. The virus can be maintained in an enzootic cycle involving Aedes mosquitoes which are able to transmit the
virus vertically to their offspring. Epizootic outbreaks are often linked with unusual rains or warm seasons, favoring the hatching of infected Aedes
eggs that are then able to initiate the virus circulation. Subsequently, large numbers of secondary vectors belonging to the Culex genus could be
infected and induce the emergence of epidemic/epizootic outbreaks. Transmission to humans occurs through direct contact with high virus
loads when aborted fetuses are manipulated.
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(1) RVFV has been detected and isolated from three
mosquito species, namely: An. coustani, An.
squamosus/cydipis and Cx. antennatus, captured in
three districts of the province of Fianarantsoa, in
the Central Highlands [39]; (2) a risk factor study
carried out with cattle in 2009 reinforced this
assumption [30]; and lastly, (3) their zoophilic and
opportunistic anthropophilic behavior in the absence
of household hosts allow assuming the implication
of these species in the RVF transmission in
Madagascar [40]. Other RVF vector species
identified as a potential vector in Saudi Arabia (Cx.
tritaeniorhynchus in 2000 [41], Egypt (Cx. pipiens in
1977–78 [27,42], Kenya (Ae. durbanensis and An.
pharoensis in 1981–84 [26]) have also been found in
Madagascar. During these episodes of RVF
circulation in Madagascar, no studies on vector
competence were undertaken. Indeed, the
implication of none of these eighteen species
involved in the transmission of RVFV in
Madagascar has been corroborated. But according
to their abundance, their trophic preference towards
animals (especially, zebu) and their involvement in
the transmission of RVFV in other countries, An.
coustani, An squamosus/cydippis, Cx. antennatus,
Cx. univittatus, Cx. tritaeniorhynchus, An
pharoensis, Cx. pipiens, Cx. quinquefasciatus, Ae.
durbanensis and Ae. (subgenus) Skusea could act as
potential vectors in Madagascar. The last two
species are abundant only in the southern part of
the island [43].
On the Comoros Islands, RVFV was isolated for the
first time in 2007 consecutively to important epizootics
occurring in East Africa in 2006 [32]. In 2008–2009, the
presence of RVFV was confirmed in domestic ruminants
[33,34] and in some inhabitants of Mayotte [44]. The re-
gion of the Indian Ocean presents a particular interest
for RVF emergence since human displacements and ani-
mal exchanges with continental Africa are important. In
addition, island ecosystems may present a particular bio-
diversity (usually a low specific richness but a high level
of endemism due to adaptive radiation) favouring the
occurrence of particular virus/vector/vertebrate systems.
Indeed, a recent inventory in Mayotte described 40 mos-
quito species belonging to 9 genera.
In Mayotte, an ongoing 2-year survey has been carried
out to describe diversity, population dynamics and host-
feeding patterns of mosquitoes in five ruminant farms.
Adult collections were performed every 4 weeks during
3 consecutive nights using light and CO2-baited traps.
Moreover, twenty-four-hour collections were made on
one site using human-, sheep-, and goat-baited traps to
describe host-feeding patterns and circadian activities.
After a one-year survey, about 7900 mosquitoes belong-
ing to 19 species and 4 genera (Culex, Eretmapodites,
Aedes, Anopheles) were collected during 24–48 sessions
of adult collections per site and 6 sessions of host-baited
trap collections. Culex quinquefasciatus and Eretmapodites
quinquevittatus were the most abundant species collected
on humans and sheep. Cx. quinquefasciatus and Er.
quinquevittatus were shown to develop low to moderate
infection rates [45]. In host-baited traps, two anthro-
pophilic mosquitoes Culex antennatus and Aedes
albopictus, and Culex decens, a non-mammalophilic mos-
quito, were found abundantly. Other species were cap-
tured at lower densities in CO2 or light-baited traps.
Eretmapodites subsimplicipes and Aedes aegypti were
found in host-baited traps but not in CO2 or light-baited
traps highlighting the need for complementary methods to
be included such as larval collections to better describe
mosquito diversity and abundance.
3. Virus-vector interactions
Three major RVFV lineages are described corresponding
to Egyptian, West African and East African strains [46].
Interestingly, the virus isolated in Madagascar in 1990
belongs to the same lineage as the Kenyan isolate of 1997
[47]. RVFV strains isolated from the Arabian Peninsula
were closely related to the Kenyan isolates [41,48,49]. By
analyzing more carefully each of the three segments of the
genome, several strains resulted from reassortments be-
tween strains from different genotypes [50]. Such a
phenomenon is not unexpected for a virus with a seg-
mented genome but this could be a strategy for selecting
more virulent viral strains.
Most arboviruses are RNA viruses, although they use a
variety of strategies to ensure their replication and trans-
mission. The feature that best distinguishes RNA is their
high mutation rate during replication ranging from 10-3-
10-5 substitutions per nucleotide and per round of copying
[51]. The main factor contributing to such high mutation
rates is a lack of proof-reading repair activities that is asso-
ciated with RNA replicases [52]. High mutation rates,
short replication times and large population sizes, ensure
the existence of the quasispecies genome pool [53]. How-
ever, arboviruses are relatively stable in nature suggesting
that the alternating host cycle (between vertebrate and in-
vertebrate hosts) constrains viral evolution by a strong
conservative sequence selection. Serial passages in a single
cell type (mammalian or insect cells) led to the loss of
RVF virulence. Large deletions were observed in the NSs
gene. Thus, genetic material non-essential to viral replica-
tion such as NSs is rapidly eliminated leading to the loss
of virulence [54]. It is tempting to speculate that direct
transmission among animals or from animals to humans
may favor the attenuation of NSs leading to the mainten-
ance of avirulent RVFV strains. Virulence is likely to be
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restored when alternation is initiated again. Indeed, verte-
brates are subject to acute infections with clearance of the
virus triggered by immune defense when vectors sustain
persistent viral replication becoming the site of genetic
changes such as reassortments. Such rearrangements may
lead to restore virulence with the acquisition of a complete
NSs gene in the course of virus replication [50]. This re-
sult agrees with observations on the natural evolution of
RVF outbreaks whose intensity declines with increasing
herd immunity and declining vector populations.
4. Diagnosis and surveillance
As described in many African countries, the virus may
circulate at a very low level, silently, without or with few
clinical signs: this cryptic transmission is extremely diffi-
cult to detect [55]. In Mayotte, in 2004, where a sero-
prevalence of up to 22% (130 animals tested) was
estimated in small ruminants without any clinical symp-
toms, RVF was diagnosed in a human case presenting
brain disorders. Susceptible animals were present in
densities high enough to ensure virus circulation but too
low to induce waves of abortions and animal mortalities.
To detect RVFV, several approaches are available: mo-
lecular detection (RT-PCR, real-time quantitative RT-PCR),
virus antigen detection, and anti-RVF IgM or IgG anti-
body detection [56]. The main drawback of medical la-
boratories in the Indian Ocean region remains the
weakness of diagnostic tools. Indeed, some diagnosis of
RVF can only be achieved in well-furnished laboratories,
with a range of standardized diagnostic reagents involving
experienced personal used to manipulating serial numbers
of strains. Another issue is the difficulty in maintaining
the cold chain, particularly when distances are important
as in Madagascar, between the field and the laboratory;
samples must be stored at −80 °C for further viral isola-
tion. Thus, appropriate containers and ice packs for
transportation allowing keeping serum samples between
−20 °C and +4 °C, should be provided to veterinary ser-
vices in charge of sample collections. This highlights the
need of an early warning system to improve transfer be-
tween the field and the laboratory.
Depending on the epidemiological status of the coun-
try, surveillance has its main purpose. In La Reunion,
Maurice and Seychelles which are RVF-free islands but
at risk for introduction, early detection of the disease is
a priority. In Mayotte, Comoros and Madagascar where
RVF is probably endemic, the priority is the detection of
any increased incidences preceding outbreaks. The epi-
demiological surveillance was heterogeneous between
the different islands: some countries had their own net-
work such as Madagascar, Mayotte or La Reunion Island
and some others received direct epidemiological informa-
tion from the field (Comoros, Maurice, and Seychelles).
Since then, a regional epidemio-surveillance network
called “AnimalRisk – OI” has been set up. All stakeholders
in the Indian Ocean involved in animal health are in-
cluded in this network (veterinary public health and re-
search institutes). A steering committee composed by the
chief veterinary officers or their deputy is in charge of de-
fining the diseases under surveillance, RVF mainly, and
data management. Once a month, the steering committee
disseminates collected epidemiological data through web
conferences and later, a quarterly epidemiological report is
produced. In endemic countries, sentinel herds have been
followed up for one year and half are used to assess the
seroconversion rate, to detect any clinical cases that could
be attributed to RVF and finally, to confirm the circulation
of RVFV despite very few notified symptoms [57]. Once the
disease is detected in humans, it is usually well-established
in animal populations. Nevertheless in Madagascar and
Mayotte in 2008, livestock infections were detected after
severe human cases were reported [32,58], highlighting
the lack of collaboration between human and animal
health services.
Given the frequent low specificity of clinical signs, syn-
dromic surveillance may be a useful and cost-effective
tool to help in controlling RVF. Indeed, this methodology
allows minimizing the main limitations of the passive sur-
veillance systems: (i) reducing the time lag between the
onset of the outbreak and the diagnosis, (ii) using a
nonspecific case definition to increase the sensitivity, and
(iii) minimizing the under-reporting by the systematic and
continuous screening of information at an earlier stage of
the disease process. On the human side in Mayotte in
2009, the surveillance of acute febrile syndromes in
humans allowed to detect 10 human RVF cases [59].
The development of models based on climatic indica-
tors and vegetation index remains promising for risk-
based surveillance implementation. These models are
available for Eastern Africa and allow forecasting RVF out-
breaks many weeks before. However, their predictive per-
formance was shown to be low for Madagascar and South
Africa, and needs to be improved and adapted to specific
Malagasy ecological and climatic conditions [60,61].
5. Prevention and control
Several control measures are described usually including
the following: (i) control of livestock movements with
respect to trade and export; (ii) vector control with an
emphasis on larvicides in vector breeding sites rather
than aerial sprayings targeting adults or (iii) vaccination
of livestock.
The role of livestock movements in RVF spread at
short or long distances -trade, transhumance- has already
been shown [31,48,62]. As a matter of fact, a large live-
stock trade exists or existed between countries in the In-
dian Ocean and countries of Eastern Africa where the
disease is endemic, and phylogenetic studies strongly
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suggest that RVFV has been introduced in the Indian
Ocean by ruminant trade [29,63].
Because RVF could be introduced through the import-
ation of domestic ruminants from infected countries, al-
though this could only occur if importation took place
within the short incubation period for the disease, adop-
tion of the recommended guidelines of the OIE Inter-
national Animal Health Code for such importations
would prevent this risk. When importing from infected
countries, veterinarian authorities should require for do-
mestic ruminants the presentation of a veterinary certifi-
cate attesting the following:
1. Vaccinated animals (a) showed no clinical signs of
RVF on the day of shipment; (b) were vaccinated
using a vaccine complying with the standards
described in the OIE Manual not less than 21 days
and not more than 90 days prior to shipment; (c) were
kept in a quarantine station in the country of origin
for the 30 days prior to shipment and showed no
clinical sign of RVF during that period.
2. Unvaccinated animals (a) showed no clinical sign of
RVF on the day of shipment; (b) were subjected to
the diagnostic tests for RVF with negative results
within 30 days before entry into quarantine; (c) were
kept in a quarantine station in the country of origin
for the 30 days prior to shipment and showed no
clinical sign of RVF during that period; (d) were
subjected to the diagnostic tests for RVF with
negative results not less than 14 days after entry into
quarantine; (e) were protected from insect vectors
during quarantine and transportation to the place of
shipment.
But to date, all these recommendations are often dis-
regarded between Tanzania and Comoros. Indeed, since
2002, importation of live animals in Comoros from
Tanzania has been common, increasing the risk of intro-
ducing continental pathogens or vectors as illustrated
with outbreaks of East Coast fever in 2003 and 2004 in
Grande Comore [62]. Once RVFV is introduced, it is
quite difficult to prevent its spread (i) between the
neighboring islands because of no quarantine park and
illegal trade and (ii) throughout countries, such as
Madagascar, where the large-scale movement of cattle is
common and often uncontrolled.
The timing of the events associated with the 2007–
2008 outbreak in the Indian Ocean and molecular epi-
demiological studies also support RVFV importation
from East Africa, possibly even during the 2006–2007
outbreak. Although most cases in the Indian Ocean
(Comoros, Mayotte and Madagascar) were reported
from January through April 2008 [32,64], epidemiologic
evidence has linked the 2008–2009 epizootics to that
occurring on the mainland a few years earlier. Especially,
clinical signs of RVF (human or animal cases) were ob-
served in early 2007 on these islands, and retrospective
investigations revealed that RVFV had been circulating
in livestock at least since December 2007 [38]. Maurice
must also be considered as an island at-risk because of
regular importations of goats from Kenya or cows from
South Africa; even if there are severe quarantine mea-
sures at Richelieu station, such as surveillance of any
clinical signs, random serological sampling, and quaran-
tine duration from 15 days to 2 months, an emphasis
should be made on surveillance to detect any sign of
RVF disease.
Beside the trade control, a safe vaccine is now available
for livestock [65-67], which is probably an efficient way
to protect both animals and humans interrupting the
virus transmission in endemic areas; even if it could be
responsible for the generation of recombinant viruses
when used in ongoing infection areas [68]. However,
socio-economic studies are needed to assess the sustain-
ability and the acceptability of measures by breeders in
the Indian Ocean context. Other ways to control the
spread of RVF involve control of the vector and protec-
tion against their bites. Larvicide controls of mosquito
breeding sites are the most effective measure of vector
control but are applicable only if breeding sites can be
clearly identified and are limited in size and extent. Dur-
ing periods of flooding, however, the number and extent
of breeding sites are usually too extended for insecticide
treatments. Besides the financial cost [69], ecological
and health issues associated with the extensive use of in-
secticides should be considered. Lastly, since the major
route of human infection is direct exposure to infected
animals [69], information of people may also ensure ap-
propriate slaughtering and consumption practices, thus
decreasing the risk of infection to humans.
6. Future of RVF on islands of the Indian Ocean
Following the 2007 Eastern Africa outbreak and the de-
tection of indigenous human cases in Mayotte in 2008
[32], a global qualitative assessment of the risk of outbreak
for Mayotte and La Reunion Island, was performed by the
French Agency for Food Safety (AFSSA, now ANSES)
[70]. The conclusions of this assessment were that the fol-
lowing: (i) the risk of outbreak in these two islands would
be rather due to the introduction of a viremic animal com-
ing either from Madagascar, Comoros or Eastern African
coasts; (ii) this risk would be rather reduced for La
Reunion Island located far from endemic areas and where
controls of imports are drastic; (iii) in Mayotte, illegal in-
troductions of ruminants are frequent enough to justify
more controls of livestock imports; (iv) in Mayotte again,
due to low animal densities, the risk for RVF to become
endemic was estimated to be very low. Therefore, a
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systematic vaccination of livestock was not recommended
[71]. Regarding the risk of human infection, AFSSA
recommended developing and/or reinforcing the informa-
tion of potentially exposed people such as breeders, veteri-
narians, slaughterhouse workers, taking into account
cultural habits. For surveillance, the implementation of an
active monitoring of sentinel herds in the main entry sites
of imported ruminants appeared as a priority.
The future of RVF in the islands of the Indian Ocean
remains unpredictable. Their proximity with the Eastern
African coast makes these islands permanently at risk.
Eco-climatic, economical, geographical and cultural con-
texts are so diverse that each island must be considered
as a special case. La Reunion Island, which is geograph-
ically isolated, is rather protected whereas the Comoro
Islands appear to be highly exposed. Seychelles and
Maurice remain RVF-free but animal trades with contin-
ental Africa keep them vulnerable. The way the virus
spread in 2008 in Madagascar demonstrated how this
country is susceptible to this disease. However the
mechanisms involved in the virus spread and its persist-
ence on the island remain partially unknown. From a
global point of view, scientific knowledge on RVF epi-
demiology in this region is poor and needs to be im-
proved. The existing predictive models are not relevant,
justifying research investment to identify the main emer-
gence and spread determinants, quantify the transmis-
sion parameters, and build models that should be used
(i) to predict the risk of emergence in space and time,
and (ii) to evaluate the efficiency of surveillance and
control measures in each context.
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